ISPO

Ovary

Neoplastic or functional ovarian cyst? a new diagnostic set-up

G Kreuzer MD, Th Paradowski MD, B Edel MD

Ovarian dysplasia (OD) diagnosed by computerized image analysis (CIA)

L Deligdisch MD, A Einstein Msc

Time-varying effect of prognostic factors in ovarian cancer

L Pache, W Kuhn, K Ulm, B Schmalfeldt, M Schmitt, F Janicke, H Graeff

The prognostic impact of markers for invasion and proliferation in ovarian cancer

B Schmalfeldt, W Kuhn, N Harbeck:, L Pache, U Reuning, P Dettmar, F Janicke, M Schmitt, H Graeff

The clinical relevance of predictive chemosensitivity testing in ovarian cancer using the MTT assay

CG Taylor MRCPath, JM Sargent BSc, AW Elgie BA, CJ Williamson HND, JG Hill FRCS

The urokinase/urokinase receptor interaction: a new target for therapy of human ovarian cancer?

O Wilhelm MD, M Schmitt PhD, R Senekowitsch MD, H Graeff MD

Transferrin-adriamycin conjugate therapy in ovarian cancer

CG Taylor MRCPath, WP Faulk MD PhD, JG Hill FRCS